Skip to main content
Clinical Trials/NCT06146140
NCT06146140
Not Yet Recruiting
N/A

Prospective, Double-Blinded, Randomized Placebo Controlled Study of an Oral Herbal Supplement on Photoaged Skin and Elasticity

Integrative Skin Science and Research0 sites36 target enrollmentDecember 1, 2023
ConditionsPhotoaging

Overview

Phase
N/A
Intervention
Not specified
Conditions
Photoaging
Sponsor
Integrative Skin Science and Research
Enrollment
36
Primary Endpoint
Change in Skin Elasticity
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to evaluate how an oral herbal supplementation influences facial skin elasticity and facial hydration as well as markers of photoaging (erythema and pigmentation).

Detailed Description

Skin is the largest organ of the body and skin aging represents a primary indicator of the aging process in the body. Photoaging is among the most crucial factors that cause skin aging damage. Photoaged skin is primarily induced by prolonged exposure to ultraviolet radiation leading to the appearance of increased skin pigmentation, reduced elasticity, and pronounced wrinkles. There has been an increasing recognition of the influence of nutrition on skin health with dietary elements emerging as a viable alternative approach to preventing photoaging. The aim of this study is to understand how oral supplementation impacts photoaged skin, facial hydration, and facial elasticity.

Registry
clinicaltrials.gov
Start Date
December 1, 2023
End Date
December 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women who are 35 to 55 years of age

Exclusion Criteria

  • Individuals who are pregnant or breastfeeding.
  • Prisoners.
  • Adults unable to consent.
  • Those who are unwilling to discontinue topical probiotics, topical hydroquinone, retinoids, bakuchiol, vitamin C, or acetyl zingerone containing products for two weeks to meet the washout criteria prior to enrolling.
  • Subjects with any of the following facial cosmetic treatments in the past 3 months or those who are unwilling to withhold the following facial cosmetic treatments during the study including botulinum toxin, injectable fillers, microdermabrasion, intense pulsed light (IPL), peels, laser treatments, acid treatments, facial plastic surgery, or any other medical treatment administered by a physician or skin care professional which is designed to improve the appearance of facial skin.
  • Individuals who have changed any of their hormonal based contraception within 3 months prior to joining the study.
  • Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years.
  • Any known allergy to any of the ingredients in the study product.
  • Those who have been on an oral antibiotic within 1 month prior enrolling
  • Those who are unwilling to discontinue oral probiotics-based supplementation or supplement ingredients found in the study's oral, product 1 month prior to enrollment

Outcomes

Primary Outcomes

Change in Skin Elasticity

Time Frame: 8 weeks

Skin elasticity measured with a handheld non-invasive device (Cutometer, Delfin Technologies Ltd.)

Change in Skin Hydration

Time Frame: 8 weeks

The skin capacitance will be measured with a handheld non-invasive device (Skin MoistureMeterSC, Delfin Technologies Ltd.). The measurement is in arbitrary units per manufacturer.

Secondary Outcomes

  • Change in skin pigmentation intensity(8 weeks)
  • Change in appearance of facial wrinkles(8 weeks)
  • Change in the skin erythema(8 weeks)
  • Change in skin transepidermal water loss(8 weeks)
  • Self-perception of skin (changes in facial fine lines and wrinkles, firmness, etc)(8 weeks)
  • Product Tolerability(8 weeks)

Similar Trials